S6K1 inhibitors (University of Cincinnati)

N/A

Report date: 2025/01/26 17:10:40
NME

Base Information

Drug NameS6K1 inhibitors (University of Cincinnati)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRibosomal protein S6 kinase inhibitors
TargetsRibosomal protein S6 kinase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Cincinnati
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Cincinnati
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A